CLINICAL IMPLICATIONS OF ENZYME INDUCTION
- 1 July 1971
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 179 (1) , 421-431
- https://doi.org/10.1111/j.1749-6632.1971.tb46919.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in manJournal of Clinical Investigation, 1969
- Repeated derepression cycles of the glucuronolactone dehydrogenase and cytochrome P-450 in the rat liver induced by phenobarbitone administrationBiochemical Pharmacology, 1969
- The effects of phenobarbital, chloral betaine, and glutethimide administration on warfarin plasma levels and hypoprothrombinemic responses in manClinical Pharmacology & Therapeutics, 1969
- Ethanol Oxidation by Hepatic Microsomes: Adaptive Increase after Ethanol FeedingScience, 1968
- Phenylbutazone Potentiation of Anticoagulant Effect: Fluorometric Assay of WarfarinExperimental Biology and Medicine, 1968
- Influence of Age and Diet on the Induction of Hexobarbital-Metabolizing Enzymes in the MouseExperimental Biology and Medicine, 1968
- Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in manBiochemical Pharmacology, 1968
- Rapid Fluorometric Assay for Plasma WarfarinClinical Chemistry, 1967
- The effect of chloral hydrate on bishydroxycoumarin metabolism; a fatal outcomeJAMA, 1966
- Zero Order Oxidation of Tolbutamide in vivoNature, 1962